Literature DB >> 15662293

Drug interactions with paracetamol.

Maurice J Toes1, Alison L Jones, Laurie Prescott.   

Abstract

Paracetamol (acetaminophen) is one of the most commonly used analgesic antipyretic drugs worldwide, and it is widely available by prescription and over the counter (OTC). Fortunately, few clinically significant drug interactions have been documented. There is probable potentiation of hepatotoxicity following an overdose from the paracetamol metabolite NAPQI by enzyme-inducing drugs. There is considerable controversy regarding the possible interaction with warfarin in its potential to increase its anticoagulant effects because of discrepancies between observational studies and those in healthy volunteers. Otherwise, no serious adverse drug interactions with therapeutic doses of paracetamol have been confirmed in humans. Because the absorption of paracetamol is so dependent on gastric emptying, other drugs that alter gastric emptying can change its pharmacokinetics; but this would not cause serious adverse effects. Although animal experiments have demonstrated that many compounds can modify paracetamol hepatotoxicity, these are unlikely to be important at therapeutic doses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15662293     DOI: 10.1097/00045391-200501000-00009

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  8 in total

Review 1.  [Polypharmacy and pain treatment].

Authors:  Markus Gosch; Birgit Böhmdorfer; Ursula Benvenuti-Falger; Peter Dovjak; Bernhard Iglseder; Monika Lechleitner; Ronald Otto; Regina E Roller; Ulrike Sommeregger
Journal:  Wien Med Wochenschr       Date:  2010-06

2.  Identifying adults at risk of paracetamol toxicity in the acute dental setting: development of a clinical algorithm.

Authors:  N V Nayyer; J Byers; C Marney
Journal:  Br Dent J       Date:  2014-03       Impact factor: 1.626

Review 3.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

4.  Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial.

Authors:  Qian Zhang; Claire Bal-dit-Sollier; Ludovic Drouet; Guy Simoneau; Jean-Claude Alvarez; Sandrine Pruvot; Romain Aubourg; Natacha Berge; Jean-Francois Bergmann; Stéphane Mouly; Isabelle Mahé
Journal:  Eur J Clin Pharmacol       Date:  2010-12-30       Impact factor: 2.953

5.  Evidence of reduced oral bioavailability of paracetamol in rats following multiple ingestion of grapefruit juice.

Authors:  Nidal A Qinna; Obbei A Ismail; Tawfiq M Alhussainy; Nasir M Idkaidek; Tawfiq A Arafat
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-30       Impact factor: 2.441

6.  A prospective survey to compare the suitability profiles of over-the-counter ibuprofen and paracetamol use in a French general practitioner-controlled population.

Authors:  Pierre Pigeon; Eric Robillard; Geoffrey D Clarke; Ian Burnett
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

7.  Effects of single-dose injectable paracetamolversus propacetamol in pain management after minor gynecologic surgery: A multicenter, randomized, double-blind, active-controlled, two-parallel-group study.

Authors:  Jean Marty; Dan Benhamou; Dominique Chassard; Nicole Emperaire; Alain Roche; Annick Mayaud; Dominique Haro; Xavier Baron; Odile Hiesse-Provost
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

Review 8.  Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.

Authors:  Thomas M Caparrotta; Daniel J Antoine; James W Dear
Journal:  Eur J Clin Pharmacol       Date:  2017-10-24       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.